বাংলায় দেখুন

💊

Sparflox

Tablet

🧬 Sparfloxacin 🏢 Alco Pharma Ltd.

Generic Name Sparfloxacin

Manufacturer Alco Pharma Ltd.

Unit Price Unit Price: ৳ 16.05 (1 x 10: ৳ 160.50) Strip Price: ৳ 160.50

🔹 Indications নির্দেশনা

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pharmacology ফার্মাকোলজি

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Dosage & Administration

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Interaction মিথস্ক্রিয়া

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Contraindications

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Side Effects

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Pregnancy & Lactation

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔹 Precautions & Warnings সতর্কতা

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms:

Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis, Mycoplasma pneumoniae , or Streptococcus pneumoniae
Acute bacterial exacerbations of chronic bronchitis (ABECB) caused by Chlamydia pneumoniae, Enterobacter cloacae, Haemophilus influenzae, Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Staphylococcus aureus , or Streptococcus pneumoniae.

Sparflox is also indicated for-

Chronic Obstructive Pulmonary Disease (COPD)
Acute Maxillary Sinusitis (AMS)
Urinary tract infections including gonococcal and nongonococcal urethritis, chancroid and other sexually transmitted diseases.
Bacterial prostatitis.
Bacterial diarrhoea
Osteomyelitis
Other uses include treatment of tuberculosis in combination with rifampicin and isoniazid, treatment of leprosy in combination with standard drugs.

🔍 People also search for

Sparflox Sparflox Tablet used for Sparflox side effects Sparflox price Sparflox dose Sparflox Tablet uses Is Sparflox safe Sparflox dosage Sparflox alternative Sparflox Bangladesh Sparfloxacin Sparfloxacin price Bangladesh Tablet price Bangladesh Alco Pharma Ltd. medicine bd

💡 Frequently Asked Questions

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...

Sparflox is indicated for the treatment of adults (≥18 years of age) with the following infections caused by susceptible strains of the designated microorganisms: Community-acquired pneumonia (CAP) caused by Chlamydia pneumoniae, Haemophilus influen...

User Reviews

⭐

No reviews yet!

Be the first to share your experience.

Write a Review